News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
498,305 Results
Type
Article (56817)
Company Profile (205)
Press Release (441283)
Section
Business (137753)
Career Advice (1360)
Deals (21246)
Drug Delivery (57)
Drug Development (66740)
Employer Resources (101)
FDA (10164)
Job Trends (10606)
News (236432)
Policy (19639)
Tag
Academia (2650)
Alliances (38988)
Alzheimer's disease (1102)
Antibody-drug conjugate (ADC) (79)
Approvals (10142)
Artificial intelligence (112)
Bankruptcy (147)
Best Places to Work (8306)
Biotechnology (146)
Breast cancer (130)
Cancer (1159)
Career advice (1133)
CAR-T (70)
Cell therapy (206)
Clinical research (51898)
Collaboration (353)
Compensation (82)
COVID-19 (2147)
C-suite (83)
Data (968)
Diabetes (98)
Diagnostics (5065)
Earnings (49439)
Employer resources (90)
Events (72131)
Executive appointments (240)
FDA (10547)
Funding (275)
Gene therapy (129)
GLP-1 (429)
Government (2730)
Healthcare (13431)
Infectious disease (2204)
Inflammatory bowel disease (88)
Interviews (269)
IPO (10205)
Job creations (2633)
Job search strategy (987)
Layoffs (306)
Legal (3757)
Liver cancer (69)
Lung cancer (190)
Manufacturing (128)
Medical device (7180)
Medtech (7182)
Mergers & acquisitions (11143)
Metabolic disorders (269)
Neuroscience (1311)
NextGen Class of 2024 (4101)
Non-profit (3875)
Northern California (1132)
Obesity (134)
Opinion (153)
Patents (66)
People (40072)
Phase I (16963)
Phase II (22526)
Phase III (16748)
Pipeline (420)
Postmarket research (2310)
Preclinical (8009)
Radiopharmaceuticals (248)
Rare diseases (154)
Real estate (4388)
Regulatory (14138)
Research institute (2542)
Resumes & cover letters (195)
Southern California (961)
Startups (2697)
United States (9985)
Vaccines (459)
Weight loss (85)
Date
Today (102)
Last 7 days (622)
Last 30 days (2987)
Last 365 days (27264)
2024 (24977)
2023 (31004)
2022 (41166)
2021 (43150)
2020 (39401)
2019 (32748)
2018 (24671)
2017 (24373)
2016 (24248)
2015 (28615)
2014 (22060)
2013 (19262)
2012 (19376)
2011 (20114)
2010 (18982)
Location
Africa (611)
Arizona (87)
Asia (30859)
Australia (5936)
California (2424)
Canada (944)
China (205)
Colorado (89)
Connecticut (118)
Europe (76902)
Florida (322)
Georgia (83)
Illinois (227)
Indiana (138)
Maryland (418)
Massachusetts (2142)
Michigan (108)
Minnesota (151)
New Jersey (780)
New York (794)
North Carolina (526)
Northern California (1132)
Ohio (98)
Pennsylvania (535)
South America (715)
Southern California (961)
Texas (367)
Washington State (309)
498,305 Results for "ximbio cancer research uk boston".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic
October 24, 2024
·
3 min read
Press Releases
IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapies
October 7, 2024
·
3 min read
Drug Development
Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug Development Announce First Patient Dosed in ALETA-001 Phase 1/2 Clinical Trial in Patients with Relapsed/Refractory B-Cell Malignancies
Aleta Biotherapeutics, a clinical stage, immuno-oncology company with a CAR T-Cell Engager platform that enables cell cancer therapies to work more effectively, and Cancer Research UK’s Centre for Drug Development, announce the first patient was dosed in a Phase 1/2 clinical trial.
February 21, 2024
·
5 min read
Press Releases
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s Annual Meeting
November 6, 2024
·
5 min read
Press Releases
Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO
September 13, 2024
·
5 min read
Biotech Bay
Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities
Cancer Research UK, one of the world’s largest charitable funders of cancer research, its innovation unit, Cancer Research Horizons, and Guardant Health, Inc., a leading precision oncology company, announced a collaboration to explore the sharing of technologies, data, and insights to advance the development and precision of cancer detection and treatment.
December 4, 2023
·
5 min read
Press Releases
Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme
September 12, 2024
·
3 min read
Press Releases
Cure51 Launches NHS-Approved Study With Cambridge University Hospitals and Seven Other Leading UK Oncology Institutions to Unlock Cancer Survival Secrets
November 18, 2024
·
4 min read
Gene therapy
Lilly Opens $700M R&D Center in Boston for Genetic Medicines
Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.
August 14, 2024
·
2 min read
·
Tristan Manalac
Genetown
Cerevance Announces Presentation at Alzheimer’s Research UK Conference
Cerevance today announced plans to present a poster at the upcoming Alzheimer’s Research UK Conference, taking place in Liverpool, United Kingdom, March 20-21, 2024.
March 13, 2024
·
2 min read
1 of 49,831
Next
